EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells
β Scribed by Xiao-Feng Zhu; Zong-Chao Liu; Bin-Fen Xie; Zhi-Ming Li; Gong-Kan Feng; Dajun Yang; Yi-Xin Zeng
- Book ID
- 117466973
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 177 KB
- Volume
- 169
- Category
- Article
- ISSN
- 0304-3835
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ZD6474 is a vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. The present study was undertaken to investigate the direct antiproliferative effect of ZD6474 on human nasopharyngeal carcinoma (NPC) __in vitro__ and t
## Abstract Nasopharyngeal carcinoma (NPC) is a common cancer in South China but is rare in other parts of the world. A novel NPCβrelated gene was isolated by location candidate cloning strategy, whose expression was downβregulated in NPC. This gene was designated human NGX6 (Genbank accession AF18
## Abstract The epidermal growth factor (EGF) plays a role in the development of prostate cancer, which becomes essential after androgen resistance has emerged. The EGF receptor (EGFR) is therefore a potential target for anticancer therapy. We evaluated the effects of ZD1839 (βIressaβ), an orally a